Ind-Swift Laboratories has raised ₹424.5 crore through allotment of redeemable non-convertible debentures to two investors. The drug firm has allotted 4,245 debentures to ECAP Equities and ECL Finance, Ind-Swift Laboratories said in a BSE filing. The tenure of allotment is six years, Ind-Swift Laboratories said. Shares of Ind-Swift Laboratories jumped 4.94 per cent at ₹82.80 on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.